Summary
Congenital disorder of glycosylation type I (CDG I) represent a rapidly growing group of inherited multisystem disorders with 13 genetically established subtypes (CDG Ia to CDG Im), and a high number of biochemically unresolved cases (CDG Ix). Further diagnostic effort and prognosis counselling are very challenging in these children. In the current study, we reviewed the clinical records of 10 CDG Ix patients and compared the data with 13 CDG Ix patients published in the literature in search for specific symptoms to create clinical subgroups. The most frequent findings were rather nonspecific, including developmental delay and axial hypotonia. Several features were found that are uncommon in CDG syndrome, such as elevated creatine kinase or arthrogryposis. Distinct ophthalmological abnormalities were observed including optic nerve atrophy, cataract and glaucoma. Two subgroups could be established: one with a pure neurological presentation and the other with a neurological-multivisceral form. The first group had a significantly better prognosis. The unique presentation of microcephaly, seizures, ascites, hepatomegaly, nephrotic syndrome and severe developmental delay was observed in one child diagnosed with CDG Ik. Establishing clinical subgroups and increasing the number of patients within the subgroups may lead the way towards the genetic defect in children with a so far unsolved type of the congenital disorders of glycosylation. Raising awareness for less common, non-CDG specific clinical features such as congenital joint contractures, movement disorders or ophthalmological anomalies will encourage clinicians to think of CDG in its more unusual presentation. Clinical grouping also helps to determine the prognosis and provide better counselling for the families.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acarregui MJ, George TN, Rhead WJ (1998) Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. J Pediatr 133: 697–700.
Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG (1999) Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J 16: 669–671.
Assmann B, Hackler R, Peters V, Schaefer JR, Arndt T, Mayatepek E (2001) A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations. Neuropediatrics 32: 313–318.
Burda P, Borsig L, de Rijk-van Andel J, et al (1998) A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest 102: 647–652.
Cohn RD, Eklund E, Bergner AL, Casella JF, Woods SL, Althaus J (2006) Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylation. Pediatrics 118: e514–e521.
De Lonlay P, Seta N, Barrot S, Chabrol B, Drouin V, Gabriel BM (2001) A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 38: 14–19.
de Koning TJ, Toet M, Dorland L, et al (1998) Recurrent nonimmune hydrops fetalis associated with carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 21: 681–682.
Di Rocco M, Hennet T, Grubenmann CE, Pagliardini S, Allegri AE, Frank CG (2005) Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature. J Inherit Metab Dis 28: 1162–1164.
Eklund EA, Sun L, Westphal V, Northrop JL, Freeze HH, Scaglia F (2005) Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. J Pediatr 147: 847–850.
Erlandson A, Bjursell C, Stibler H, Kristiansson B, Wahlstrom J, Martinsson T (2001) Scandinavian CDG Ia patients: genotype/phenotype correlation and geographic origin of founder mutations. Hum Genet 108: 359–367.
Freeze HH (1998) Disorders in protein glycosylation and potential therapy: tip of an iceberg? J Pediatr 133: 593–600.
Garcia-Silva MT, Matthijs G, Schollen E, Cabrera JC, Sanchez DP, Marti HM (2004) Congenital disorder of glycosylation (CDG) type Ie. A new patient. J Inherit Metab Dis 27: 591–600.
Grünewald S, Imbach T, Huijben K, Rubio-Gozalbo ME, Verrips A, de Klerk JB (2000) Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol 47: 776–781.
Grünewald S, Matthijs G, Jaeken J (2002) Congenital disorders of glycosylation: a review. Pediatr Res 52: 618–624.
Jaeken J (2003). Komrower Lecture. Congenital disorders of glycosylation (CDG): it’s all in it! J Inherit Metab Dis 26: 99–118.
Jaeken J, Matthijs G (2001) Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet 2: 129–151.
Jaeken J, van Eijk HG, Corbeel L, Eeckels R, Eggermont E (1984) Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 144: 245–247.
Jensen H, Kjaergaard S, Klie F, Moller HU (2003) Ophthalmic manifestations of congenital disorder of glycosylation type 1a. Ophthalmic Genet 24: 81–88.
Kornak U, Reynders E, van Reeuwijk J, et al (2008) Mutations in the a2-subunit of the v-type H+-ATPase impair glycosylation in the Golgi apparatus and cause autosomal recessive cutis laxa type 2. Nat Genet 40: 32–34.
Kranz C, Denecke J, Lehle L, et al (2004) Congenital disorder of glycosylation type Ik (CDG Ik): a defect of mannosyltransferase I. Am J Hum Genet 74: 545–551.
Kranz C, Jungeblut C, Denecke J, et al (2007) A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Genet 80: 433–440.
Leonard J, Grünewald S, Clayton P (2001) Diversity of congenital disorders of glycosylation. Lancet 357: 1382–1383.
McKenzie FA, Fietz M, Fletcher J, Smith RLL, Wright IMR, Jaeken J (2007) A previously undescribed form of congenital disorder of glycosylation with variable presentation in siblings: early fetal loss with hydrops fetalis, and infant death with hypoproteinemia. Am J Med Genet 143A: 2029–2034.
Mention K, Michaud L, Dobbelaere D, Guimber D, Gottrand F, Turck D (2001) Neonatal severe intractable diarrhoea as the presenting manifestation of an unclassified congenital disorder of glycosylation (CDG x). Arch Dis Child Fetal Neonatal 85: F217–F219.
Morava E, Zeevaert R, Korsch E, et al (2007) A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 15: 638–645.
Morava E, Lefeber D, Urban Z, et al (2008) Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet 16: 28–35.
Prietsch V, Peters V, Hackler R, Jakobi R, Assmann B, Fang J (2002) A new case of CDG x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis 25: 126–130.
Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H (2001) MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 108: 1687–1695.
Schollen E, Grünewald S, Keldermans L, Albrecht B, Körner C, Matthijs G (2005) CDG Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter). Eur J Med Genet 48: 153–158.
Schwarz M, Thiel C, Lubbehusen J, Dorland B, de Koning T, von Figura K (2004) Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet 74: 472–481.
Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T (2003) A new type of congenital disorders of glycosylation (CDG Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 278: 22498–22505.
Zentilin BM, de Lonlay P, Seta N, Besnard M, Pelatan C, Ogier H (2003) Failure to thrive and intestinal diseases in congenital disorders of glycosylation. Arch Pediatr 10: 590–595.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Jaak Jaeken
Competing interests: None declared
References to electronic databases: All OMIM entries under CDG Ia–Ix Phosphomannomutase: EC 5.4.2.8. Phosphomannose isomerase: EC 5.3.1.8.
Rights and permissions
About this article
Cite this article
Morava, É., Wosik, H., Kárteszi, J. et al. Congenital disorder of glycosylation type Ix: Review of clinical spectrum and diagnostic steps. J Inherit Metab Dis 31, 450–456 (2008). https://doi.org/10.1007/s10545-008-0822-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0822-0